Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy

New England Journal of Medicine

Volumn 330, Issue 22, 1994, Pages 1560-1564

  Andersen, Judith C ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; DANAZOL; DEXAMETHASONE; IMMUNOGLOBULIN; PREDNISONE; STAPHYLOCOCCUS PROTEIN A; VINCRISTINE;

ADULT; APHERESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG COST; DRUG EFFECT; DRUG RESISTANCE; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOTHERAPY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SPLENECTOMY; THROMBOCYTE COUNT;

ADMINISTRATION, ORAL; ADULT; CHRONIC DISEASE; DEXAMETHASONE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 0028358131     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199406023302203     Document Type: Article

References (32)

1. Harrington WJ, Minnich V, Hollingsworth JW, Moore CV Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 1951; 38: 1-10
2. Shulman NR, Marder VJ, Weinrach RS Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura: physiologic, serologic and isotropic studies. Ann N Y Acad Sci 1965; 124: 499-513
3. Aster RH, Keene WR Sites of platelet destruction in idiopathic thrombocytopenic purpura. Br J Haematol 1969; 16: 61-73
4. Unkeless JC Function and heterogeneity of human Fc receptors for immunoglobulin G. J Clin Invest 1989; 83: 355-361
5. Ballem PJ, Segal GM, Stratton JR, Gernsheimer T, Adamson JW, Slichter SJ Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura: evidence of both impaired platelet production and increased platelet clearance. J Clin Invest 1987; 80: 33-40
6. Budman DR, Steinberg AD Hematologic aspects of systemic lupus erythematosus: current concepts. Ann Intern Med 1977; 86: 220-229
7. Sonnenblick M, Kramer R, Hershko C Corticosteroid responsive immune thrombocytopenia in Hodgkin's disease. Oncology 1986; 43: 349-353
8. Koller CA Immune thrombocytopenic purpura. Med Clin North Am 1980; 64: 761-773
9. McVerry BA Management of idiopathic thrombocytopenic purpura in adults. Br J Haematol 1985; 59: 203-208
10. Imbach P, Barandun S, d'Apuzzo V, High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981; 1: 1228-1231
11. Schmidt RE, Budde U, Schafer G, Stroehmann I High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura. Lancet 1981; 2: 475-476
12. Schmidt RE, Budde U, Broschen-Zywietz C, Schafer G, Mueller-Eckhardt C High dose gammaglobulin therapy in adults with idiopathic thrombocytopenic purpura (ITP): clinical effects. Blut 1984; 48: 19-24
13. Bussel JB, Pham LC Intravenous treatment with gammaglobulin in adults with immune thrombocytopenic purpura: review of the literature. Vox Sang 1987; 52: 206-211
14. Bussel JB, Pham LC, Aledort L, Nachman R Maintenance treatment of adults with chronic refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobulin. Blood 1988; 72: 121-127
15. Ahn YS, Harrington WJ, Mylvaganam R, Allen LM, Pall LM Slow infusion of vinca alkaloids in the treatment of idiopathic thrombocytopenic purpura. Ann Intern Med 1984; 100: 192-196
16. Strother SV, Zuckerman KS, LoBuglio AF Colchicine therapy for refractory idiopathic thrombocytopenic purpura. Arch Intern Med 1984; 144: 2198-2200
17. McVerry BA, Auger M, Bellingham AJ The use of danazol in the management of chronic immune thrombocytopenic purpura. Br J Haematol 1985; 61: 145-148
18. Ahn YS, Mylvaganam R, Garcia RO, Kim CI, Palow D, Harrington WJ Low-dose danazol therapy in idiopathic thrombocytopenic purpura. Ann Intern Med 1984; 107: 177-181
19. Berchtold P, McMillan R Therapy of chronic idiopathic thrombocytopenic purpura in adults. Blood 1989; 74: 2309-2317
20. Salama A, Kiefel V, Mueller-Eckhardt C Effect of IgG anti-Rho(D) in adult patients with chronic autoimmune thrombocytopenia. Am J Hematol 1986; 22: 241-250
21. Kelsey PR, Schofield KP, Geary CG Refractory idiopathic thrombocytopenic purpura (ITP) treated with cyclosporine. Br J Haematol 1985; 60: 197-198
22. Blanchette VS, Hogan VA, McCombie NE, Intensive plasma exchange therapy in ten patients with idiopathic thrombocytopenic purpura. Transfusion 1984; 14: 388-394
23. Guthrie TH Jr, Oral A Immune thrombocytopenic purpura: a pilot study of staphylococcal protein A immunomodulation in refractory patients. Semin Hematol 1989; 26: Suppl 1: 3-9
24. von dem Borne AEGK, Vos JJE, Pegels JG, Thomas LLM, van der Lelie H High dose intravenous methylprednisolone or high dose intravenous gammaglobulin for autoimmune thrombocytopenia. BMJ 1988; 296: 249-250
25. Figueroa M, Gehlsen J, Hammond D, Combination chemotherapy in refractory immune thrombocytopenic purpura. N Engl J Med 1993; 328: 1226-1229
26. Alexanian R, Barlogie B, Dixon D High-dose glucocorticoid treatment of resistant myeloma. Ann Intern Med 1986; 105: 8-11
27. Buzaid AC, Durie BGM Management of refractory myeloma: a review. J Clin Oncol 1988; 6: 889-905
28. Dalton WS, Durie BGM, Alberts DS, Gerlach JH, Cress AE Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein. Cancer Res 1986; 46: 5125-5130
29. LoBuglio AF, Court WS, Vinocur L, Maglott G, Shaw GM Immune thrombocytopenic purpura: use of a 125I-labeled antihuman IgG monoclonal antibody to quantify platetet-bound IgG. N Engl J Med 1983; 309: 459-463
30. Wilson WH, Bryant G, Bates S, EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma. J Clin Oncol 1993; 11: 1573-1582
31. Rothfield N. Systemic lupus erythematosus: clinical aspects and treatment. In: McCarty DJ, ed. Arthritis and allied conditions: a textbook of rheumatology. 11th ed. Philadelphia: Lea & Febiger, 1989:1022-48.
32. Picozzi VJ, Roeske WR, Creger WP Rate of therapy failures in adult idiopathic thrombocytopenic purpura. Am J Med 1980; 69: 690-694